Antonia Ávila-Flores

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Respiratory Syndrome Coronavirus

Dendritic Cells

Tyrosine Kinase

Transcription Factor

Top Venues

Cancer immunology, immunotherapy : CII

International journal of molecular sciences

Centro Nacional de Biotecnología

Centro de Investigaciones y Estudios Superiores (CINVESTAV) (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centro Nacional de Biotecnología Feb 01 2003

Spain

Senior Scientist :: Department of Immunology and Oncology

Centro de Biología Molecular Severo Ochoa (CBM-SO)

Spain

Research Fellow

Education History

Centro de Investigaciones y Estudios Superiores (CINVESTAV)

Mexico

PHD :: Physiology, Biophysics and Neurosciences

Publications

Antonia Ávila-Flores, Juan José Sánchez-Cabezón, Ane Ochoa-Echeverría, Ana I Checa, Jorge Rosas-García, Mariana Téllez-Araiza, Sara Casado, Rosa Liébana, Teresa Santos-Mendoza, Isabel Merida
Identification of Host PDZ-Based Interactions with the SARS-CoV-2 E Protein in Human Monocytes. International journal of molecular sciences 24 (16) (2023)
Dante Barreda, César Santiago, Juan R Rodríguez, José F Rodríguez, Jose M Casasnovas, Isabel Merida, Antonia Ávila-Flores
SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Promote a Proinflammatory Activation Profile on Human Dendritic Cells. Cells 10 (12) (2021)
Javier Arranz-Nicolás, Miguel Martin-Salgado, Irene Adán-Barrientos, Rosa Liébana, María Del Carmen Moreno-Ortíz, Judith Leitner, Peter Steinberger, Antonia Ávila-Flores, Isabel Merida
Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program. Cancer immunology, immunotherapy : CII 70 (11) (2021)
Javier Arranz-Nicolás, Jesús Ogando, Denise Soutar, Raquel Arcos-Pérez, Daniel Meraviglia-Crivelli, Santos Mañes, Isabel Merida, Antonia Ávila-Flores
Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals. Cancer immunology, immunotherapy : CII 67 (6) (2018)